Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
In this type of stage IIIA non-small cell lung cancer, the cancer has not spread to distant organs, but the tumor may or may not have (N1 vs. N0) spread to the lymph nodes within the lung and/or the area where the bronchus meets the lung. One or more of the following features will also be present:bout 30 percent of those diagnosed with lung cancer are at stage III at the time of diagnosis. The five-year survival rate for stage IIIA lung cancer varies widely, and is about 23 percent on average. For stage IIIB lung cancer, the survival rate is around 10 percent.